Feedback / Questions
resomelagon (AP1189) - SynAct Pharma
https://www.tradingview.com/news/reuters.com,2025-06-04:newsml_MFN1wxdpH:0-synact-pharma-refines-development-strategy-for-lead-compound-resomelagon-ap1189/
Jun 4, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next